Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Skin Neoplasms | 9 | 2024 | 897 | 3.290 |
Why?
|
| Erythema | 3 | 2023 | 29 | 1.810 |
Why?
|
| Carcinoma, Verrucous | 2 | 2024 | 4 | 1.710 |
Why?
|
| Drug Hypersensitivity Syndrome | 2 | 2024 | 8 | 1.690 |
Why?
|
| Thigh | 2 | 2023 | 51 | 1.640 |
Why?
|
| Herpesvirus 6, Human | 2 | 2024 | 55 | 1.630 |
Why?
|
| Skin Diseases, Bacterial | 2 | 2022 | 23 | 1.550 |
Why?
|
| Population Health | 2 | 2023 | 40 | 1.530 |
Why?
|
| Drug Eruptions | 2 | 2024 | 33 | 1.010 |
Why?
|
| Keloid | 2 | 2024 | 11 | 0.990 |
Why?
|
| Eosinophilia | 2 | 2024 | 106 | 0.940 |
Why?
|
| Erythromelalgia | 1 | 2024 | 1 | 0.910 |
Why?
|
| Leg | 2 | 2022 | 134 | 0.880 |
Why?
|
| Roseolovirus Infections | 1 | 2024 | 30 | 0.860 |
Why?
|
| Keratosis | 1 | 2024 | 17 | 0.860 |
Why?
|
| Virus Activation | 1 | 2024 | 85 | 0.840 |
Why?
|
| Heel | 1 | 2023 | 9 | 0.840 |
Why?
|
| Pemphigoid, Bullous | 1 | 2023 | 5 | 0.820 |
Why?
|
| Alopecia Areata | 1 | 2023 | 11 | 0.820 |
Why?
|
| Teratogenesis | 1 | 2023 | 8 | 0.800 |
Why?
|
| Retinoids | 2 | 2022 | 27 | 0.800 |
Why?
|
| Acne Vulgaris | 1 | 2023 | 25 | 0.790 |
Why?
|
| Lichen Planus | 1 | 2022 | 9 | 0.780 |
Why?
|
| Dermatology | 1 | 2023 | 31 | 0.780 |
Why?
|
| Skin Abnormalities | 1 | 2022 | 35 | 0.760 |
Why?
|
| Biological Therapy | 1 | 2022 | 24 | 0.750 |
Why?
|
| Exanthema | 1 | 2023 | 74 | 0.750 |
Why?
|
| Abortion, Spontaneous | 1 | 2023 | 84 | 0.740 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2023 | 104 | 0.740 |
Why?
|
| Drugs, Essential | 1 | 2021 | 7 | 0.730 |
Why?
|
| Hyperpigmentation | 2 | 2018 | 13 | 0.720 |
Why?
|
| Alcoholism | 1 | 2023 | 250 | 0.680 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2023 | 236 | 0.670 |
Why?
|
| Face | 1 | 2022 | 189 | 0.660 |
Why?
|
| Toes | 1 | 2020 | 27 | 0.640 |
Why?
|
| Skin Diseases | 1 | 2021 | 134 | 0.640 |
Why?
|
| Fibroma | 1 | 2020 | 31 | 0.630 |
Why?
|
| Databases, Factual | 1 | 2024 | 1230 | 0.620 |
Why?
|
| BRCA1 Protein | 1 | 2019 | 81 | 0.590 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2019 | 74 | 0.570 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2019 | 69 | 0.570 |
Why?
|
| Xanthogranuloma, Juvenile | 1 | 2018 | 34 | 0.560 |
Why?
|
| Humans | 31 | 2024 | 132202 | 0.550 |
Why?
|
| Antiviral Agents | 1 | 2023 | 822 | 0.540 |
Why?
|
| Darier Disease | 1 | 2014 | 4 | 0.460 |
Why?
|
| Rickettsia rickettsii | 1 | 2014 | 3 | 0.430 |
Why?
|
| Rocky Mountain Spotted Fever | 1 | 2014 | 7 | 0.430 |
Why?
|
| Blister | 2 | 2023 | 22 | 0.420 |
Why?
|
| Edema | 2 | 2023 | 148 | 0.380 |
Why?
|
| Sulfonamides | 1 | 2014 | 281 | 0.370 |
Why?
|
| Lower Extremity | 2 | 2023 | 188 | 0.360 |
Why?
|
| Melanoma | 1 | 2019 | 954 | 0.360 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 3357 | 0.280 |
Why?
|
| Neoplasms | 1 | 2022 | 2944 | 0.270 |
Why?
|
| Cicatrix | 2 | 2018 | 123 | 0.250 |
Why?
|
| Case-Control Studies | 2 | 2023 | 3418 | 0.240 |
Why?
|
| Laser Therapy | 2 | 2017 | 232 | 0.230 |
Why?
|
| Fingers | 1 | 2024 | 67 | 0.210 |
Why?
|
| Jurisprudence | 1 | 2023 | 14 | 0.200 |
Why?
|
| Vitamin A | 1 | 2023 | 59 | 0.200 |
Why?
|
| Teratogens | 1 | 2023 | 86 | 0.190 |
Why?
|
| Alopecia | 1 | 2022 | 40 | 0.190 |
Why?
|
| Torso | 1 | 2022 | 13 | 0.190 |
Why?
|
| Nose | 1 | 2022 | 103 | 0.180 |
Why?
|
| World Health Organization | 1 | 2021 | 118 | 0.170 |
Why?
|
| Head | 1 | 2022 | 115 | 0.170 |
Why?
|
| Dermatologic Surgical Procedures | 2 | 2018 | 42 | 0.170 |
Why?
|
| Female | 7 | 2024 | 70742 | 0.170 |
Why?
|
| Autoantibodies | 1 | 2023 | 459 | 0.160 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 803 | 0.160 |
Why?
|
| Acrospiroma | 1 | 2019 | 4 | 0.150 |
Why?
|
| Sweat Gland Neoplasms | 1 | 2019 | 16 | 0.150 |
Why?
|
| Facial Neoplasms | 1 | 2019 | 21 | 0.150 |
Why?
|
| Skin | 1 | 2022 | 540 | 0.150 |
Why?
|
| Groin | 1 | 2018 | 14 | 0.150 |
Why?
|
| Feasibility Studies | 1 | 2021 | 825 | 0.140 |
Why?
|
| Hypopigmentation | 1 | 2018 | 11 | 0.140 |
Why?
|
| Middle Aged | 3 | 2024 | 28869 | 0.140 |
Why?
|
| United States | 2 | 2024 | 11617 | 0.140 |
Why?
|
| Cicatrix, Hypertrophic | 1 | 2017 | 6 | 0.140 |
Why?
|
| Prevalence | 1 | 2024 | 2664 | 0.140 |
Why?
|
| Surgical Wound | 1 | 2017 | 23 | 0.130 |
Why?
|
| Comorbidity | 1 | 2022 | 1605 | 0.130 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 3740 | 0.120 |
Why?
|
| Keratolytic Agents | 1 | 2014 | 6 | 0.110 |
Why?
|
| Burnout, Professional | 1 | 2017 | 133 | 0.110 |
Why?
|
| Pruritus | 1 | 2014 | 42 | 0.110 |
Why?
|
| Thorax | 1 | 2014 | 73 | 0.110 |
Why?
|
| Tretinoin | 1 | 2014 | 102 | 0.110 |
Why?
|
| Male | 5 | 2024 | 65011 | 0.110 |
Why?
|
| Dihydropteroate Synthase | 1 | 2014 | 3 | 0.110 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2014 | 9 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1963 | 0.110 |
Why?
|
| Contraindications | 1 | 2014 | 75 | 0.110 |
Why?
|
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2014 | 45 | 0.110 |
Why?
|
| Infant | 2 | 2020 | 13184 | 0.100 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 7105 | 0.100 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2014 | 382 | 0.090 |
Why?
|
| Physicians | 1 | 2017 | 634 | 0.080 |
Why?
|
| Young Adult | 1 | 2024 | 9935 | 0.080 |
Why?
|
| Pregnancy | 1 | 2023 | 7561 | 0.080 |
Why?
|
| Adult | 2 | 2024 | 31599 | 0.080 |
Why?
|
| Aged | 2 | 2024 | 21360 | 0.070 |
Why?
|
| Dermabrasion | 2 | 2018 | 4 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 1829 | 0.070 |
Why?
|
| Internship and Residency | 1 | 2017 | 1248 | 0.060 |
Why?
|
| Adolescent | 1 | 2024 | 20520 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 2556 | 0.050 |
Why?
|
| Chin | 1 | 2019 | 4 | 0.040 |
Why?
|
| Esthetics | 1 | 2018 | 38 | 0.040 |
Why?
|
| Onions | 1 | 2017 | 2 | 0.040 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2017 | 8 | 0.040 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2017 | 13 | 0.040 |
Why?
|
| Low-Level Light Therapy | 1 | 2018 | 19 | 0.030 |
Why?
|
| Verapamil | 1 | 2017 | 50 | 0.030 |
Why?
|
| Dermatologic Agents | 1 | 2018 | 30 | 0.030 |
Why?
|
| Dermal Fillers | 1 | 2017 | 4 | 0.030 |
Why?
|
| Calcium Channel Blockers | 1 | 2017 | 115 | 0.030 |
Why?
|
| Platelet-Rich Plasma | 1 | 2017 | 19 | 0.030 |
Why?
|
| Accreditation | 1 | 2017 | 94 | 0.030 |
Why?
|
| Plant Extracts | 1 | 2017 | 135 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 338 | 0.030 |
Why?
|
| Biopsy | 1 | 2019 | 1287 | 0.030 |
Why?
|
| Wound Healing | 1 | 2017 | 480 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 564 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 13012 | 0.010 |
Why?
|